Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation
2007
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence
2006
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Aspirin for Preventing the Recurrence of Venous Thromboembolism
2012
Multiple myeloma
2014
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review
2003
Control of cancer-related anemia with erythropoietic agents:a review of evidence for improved quality of life and clinical outcomes
2003
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes
2010
Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis
2011
A pilot study of central venous catheter survival in cancer patients using low‐molecular‐weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)
2007
Evidence-Based Management of Anticoagulant Therapy
2012
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study
2009
Risk factors for catheter-related thrombosis in cancer patients
2004
Apixaban for Extended Treatment of Venous Thromboembolism
2012
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
2009
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy
2010
Prognostic Value of ECG Among Patients with Acute Pulmonary Embolism and Normal Blood Pressure
2009
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
2013
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
2008
Treatment of Deep-Vein Thrombosis
2004
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
2013
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease
2004
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Deep Venous Thrombosis
2004
Platelet Activation and Atherothrombosis
2007 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
2005
Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy: The Balance of Benefits and Harms
2007
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
2011
Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters
2010
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
2006
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism
2006
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Thromboembolism after pneumonectomy for malignancy: An independent marker of poor outcome
2006
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Effect of Study Setting on Anticoagulation Control
2006
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation
2009
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
2004
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study
2009
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
2015
Idarucizumab for Dabigatran Reversal
2015 Standout
Prevention of Venous Thromboembolism
2008 Standout
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
2003
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
2009
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2012
Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer
2006
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies
2010
Epoetin alfa improves quality of life in patients with cancer
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Deep vein thrombosis
2005
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
2011
D‐dimer, factor VIII coagulant activity, low‐intensity warfarin and the risk of recurrent venous thromboembolism
2006
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma
2010
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
2006
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
2004
Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin
2013
Hemorrhagic Complications of Anticoagulant Treatment
2004
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
2012
Anemia of Chronic Disease
2005 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Deep vein thrombosis associated with central venous catheters – a review
2005
Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial
2004
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
2005
Venous Thromboembolism and Cancer: Risks and Outcomes
2003
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer
2006
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
2007 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis
2009
Invasive Approaches to Treatment of Venous Thromboembolism
2004
Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
The risk of bleeding with warfarin: A systematic review and performance analysis of clinical prediction rules
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
2014
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study
2008
Emerging Targets in Photopharmacology
2016 StandoutNobel
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Multiple Myeloma
2011 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of Sean Dolan being referenced
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7
2006
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
2003
Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
2004
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial
2008
A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer
2003
Epoetin Alfa Therapy Increases Hemoglobin Levels and Improves Quality of Life in Patients With Cancer-Related Anemia Who Are Not Receiving Chemotherapy and Patients With Anemia Who Are Receiving Chemotherapy
2001
Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer
2005